![]() ![]() Repevax and Boostrix IPV both protect against whooping cough, diphtheria, tetanus and polio, but they are made by different manufacturers.īut the manufacturer's leaflet says there's no information on the use of Boostrix IPV in pregnancy. Why is Boostrix IPV replacing Repevax as the recommended vaccine? Which whooping cough vaccine will I be given?Īs there is no whooping cough-only vaccine, the vaccine you'll be given also protects against polio, diphtheria and tetanus. Until July 2014, a vaccine called Repevax was used, but from July 2014 the vaccine you'll be offered is called Boostrix IPV.īoostrix IPV is similar to the 4-in-1 vaccine – the pre-school booster that's routinely given to children before they start school. Published research from the UK vaccination programme shows that vaccinating pregnant women against whooping cough has been highly effective in protecting young babies until they can have their first vaccination when they are two months old.īabies born to women vaccinated at least a week before birth had a 91% reduced risk of becoming ill with whooping cough in their first weeks of life, compared to babies whose mothers had not been vaccinated.Īn additional benefit is that the protection the mother receives from the vaccination will lower her own risk of infection and of passing whooping cough on to her baby. Is whooping cough vaccination in pregnancy working? To date, around 60% of eligible pregnant women (over half a million) have received the whooping cough vaccine with no safety concerns being identified in the baby or mother.Ī number of other countries, including the US and New Zealand, currently recommend vaccination against whooping cough in pregnancy. Rates of normal, healthy births were similar to those seen in unvaccinated women. The results showed that in women given whooping cough vaccination in the third trimester (after 28 weeks), there is no evidence of an increased risk of any of these outcomes. The study looked at several outcomes, including stillbirth, premature birth, death of the baby within 28 days of birth, foetal distress, caesarean delivery, low birthweight, or renal (kidney) failure in the baby, all serious events that can occur naturally in pregnancy. The MHRA's study of around 20,000 vaccinated women has found no evidence of risks to pregnancy or babies. Pertussis-containing vaccine (whooping cough vaccine) has been used routinely in pregnant women in the UK since October 2012, and the Medicines and Healthcare Products Regulatory Agency (MHRA) is carefully monitoring its safety. It's understandable that you might have concerns about the safety of having a vaccine during pregnancy, but there's no evidence to suggest the whooping cough vaccine is unsafe for you or your unborn baby. Is the whooping cough vaccine safe in pregnancy? The immunity you get from the vaccine will pass to your baby through the placenta and provide passive protection for them until they are old enough to be routinely vaccinated against whooping cough at two months old. Getting vaccinated while you’re pregnant is highly effective at protecting your baby from developing whooping cough in the first few weeks of their life. Why are pregnant women advised to have the whooping cough vaccine? Pregnant women can safely help protect their babies by getting vaccinated – ideally after they are 16 weeks pregnant, although they may be given the vaccine up to 38 weeks of pregnancy. When whooping cough is particularly severe, they can die. Young babies with whooping cough are often very unwell and most will be admitted to hospital because of their illness. There's a lot of whooping cough (pertussis) around at the moment and babies who are too young to start their vaccinations are at greatest risk. Whooping cough vaccine for pregnant women Printer friendly version (opens new window) ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |